The combination of oral contraceptive medication and genetic thrombophilia significantly increases the risk of CVT, especially in women with factor V Leiden mutation, prothrombin gene mutation, and hyperhomocysteinemia [17,18,19,20]. The gene discussed is F5; the disease is hyperhomocysteinemia.